Key facts
| Price (PPV) | 70 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | valsartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09CA03 |
| Manufacturer | PHI |
| Presentation | Boite de 28 |
| Nature | Médicament |
| Hospital price | 43.80 MAD |
| Data collected on | 9/8/2026 |
Indications
Hypertension Traitement de l’hypertension artérielle essentielle chez les adultes, et de l’hypertension chez les enfants et les adolescents âgés de 6 ans à moins de 18 ans. Post-infarctus du myocarde récent Traitement des patients adultes cliniquement stables présentant une insuffisance cardiaque symptomatique ou une dysfonction systolique ventriculaire gauche asymptomatique post-infarctus du myocarde récent (entre 12 heures et 10 jours). Insuffisance cardiaque Traitement des patients adultes présentant une insuffisance cardiaque symptomatique en cas d’intolérance aux inhibiteurs de l’enzyme de conversion (IEC), en cas d’intolérance aux bêtabloquants, comme traitement additionnel à un IEC quand les antagonistes de l’aldostérone ne peuvent pas être utilisés.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Vartex 40 mg (SOTHEMA) contains the same active substance as Valphi 40 mg (Valsartan) at the same strength, but in a different pack: Boite de 14 at 44.80 MAD, i.e. 3.20 MAD per unit against 2.50 MAD for Valphi 40 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Vartex 40 mg | SOTHEMA | Boite de 28 | 78.80 MAD | 2.81 / unit | — |
| Tareg 40 mg | NOVARTIS PHARMA MAROC | Boîte de 28 | 98.40 MAD | 3.51 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Vartex 40 mg | SOTHEMA | Boite de 14 | 44.80 MAD | 3.20 / unit |
| Zenovan 40 mg | ZENITH PHARMA | Boite de 30 | 82.50 MAD | 2.75 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Valphi 40 mg
Valphi 40 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by PHI and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Valphi 40 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Valphi 40 mg
Answers to common questions from Moroccan patients about this drug.